![Nina Jobst](https://cdn.statcdn.com/static/../CMS/contactperson/ERI1709_1623311468.png)
Research and development expenses of NeoPharm 2017-2023
In 2023, the research and development (R&D) expenses of South Korean cosmetics company Neopharm amounted to roughly 2.65 billion South Korean won, a decrease compared to the previous year. The company's R&D expenses jumped up from 2017 to 2018, and spending on R&D has increased overall despite having minor decreases for some of the years.